FI893545L - Maenskans protein c-mutanter och foerfarande foer deras framstaellning. - Google Patents

Maenskans protein c-mutanter och foerfarande foer deras framstaellning. Download PDF

Info

Publication number
FI893545L
FI893545L FI893545A FI893545A FI893545L FI 893545 L FI893545 L FI 893545L FI 893545 A FI893545 A FI 893545A FI 893545 A FI893545 A FI 893545A FI 893545 L FI893545 L FI 893545L
Authority
FI
Finland
Prior art keywords
mutanter
maenskans
protein
foerfarande foer
och foerfarande
Prior art date
Application number
FI893545A
Other languages
English (en)
Other versions
FI893545A0 (fi
FI893545A7 (fi
Inventor
Tamotsu Hashimoto
Masahiro Sato
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of FI893545A0 publication Critical patent/FI893545A0/fi
Publication of FI893545L publication Critical patent/FI893545L/fi
Publication of FI893545A7 publication Critical patent/FI893545A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
FI893545A 1988-07-26 1989-07-24 Ihmisen proteiini C:n mutantteja ja menetelmä niiden valmistamiseksi FI893545A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18453888 1988-07-26

Publications (3)

Publication Number Publication Date
FI893545A0 FI893545A0 (fi) 1989-07-24
FI893545L true FI893545L (fi) 1990-01-27
FI893545A7 FI893545A7 (fi) 1990-01-27

Family

ID=16154955

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893545A FI893545A7 (fi) 1988-07-26 1989-07-24 Ihmisen proteiini C:n mutantteja ja menetelmä niiden valmistamiseksi

Country Status (8)

Country Link
EP (1) EP0352651A1 (fi)
JP (1) JP2728240B2 (fi)
KR (1) KR910003095A (fi)
AU (1) AU3890689A (fi)
DK (1) DK366589A (fi)
FI (1) FI893545A7 (fi)
IE (1) IE892412L (fi)
PT (1) PT91268A (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE163048T1 (de) * 1989-12-29 1998-02-15 Zymogenetics Inc Hybrides protein c
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
US20010006967A1 (en) * 1992-09-21 2001-07-05 Stanley M. Crain Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists
SV1999000067A (es) * 1998-06-01 2000-07-06 Lilly Co Eli Proteina humana c polipeptida ref. x-12279
CA2391651A1 (en) * 1999-11-19 2001-05-25 Eli Lilly And Company Protein c derivatives
KR100576180B1 (ko) * 2002-07-27 2006-05-03 주식회사 한화 비폭발성 에멀젼 조성물
AU2003280316A1 (en) * 2002-11-11 2004-06-03 Maxygen Aps Zymogen-like protein c polypeptides
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
KR102744525B1 (ko) * 2021-12-29 2024-12-18 주식회사 한화 저비중 에멀젼 폭약 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341228C (en) * 1985-06-27 2001-05-15 Mark J. Murray Expression of protein c
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
FI882746L (fi) * 1987-06-12 1988-12-13 Hoechst Japan Hybridprotein c och foerfarande foer dess framstaellning.

Also Published As

Publication number Publication date
DK366589A (da) 1990-01-27
JPH02167096A (ja) 1990-06-27
AU3890689A (en) 1990-02-01
PT91268A (pt) 1990-02-08
FI893545A0 (fi) 1989-07-24
KR910003095A (ko) 1991-02-26
EP0352651A1 (en) 1990-01-31
JP2728240B2 (ja) 1998-03-18
FI893545A7 (fi) 1990-01-27
DK366589D0 (da) 1989-07-25
IE892412L (en) 1990-01-26

Similar Documents

Publication Publication Date Title
FI891729L (fi) Hartslaminat och foerfarande foer deras framstaellning.
FI892004L (fi) Dammsugare och filterpaose daertill.
FI880206A0 (fi) Tryckgivarkonstruktion och foerfarande foer framstaellning daerav.
FI890622A0 (fi) Elektriskt ledande polymerer och deras framstaellning.
FI885606A7 (fi) Banformningsfoerfarande och anordning.
FI890213L (fi) Kefalosporinsalter och injicerbara kompositioner.
FI880298L (fi) Testanordning foer fordonsdaeck och slirskydd.
FI890825L (fi) Polyamid-imidloesningar och foerfarande foer deras framstaellning.
FI890905L (fi) Svaorantaendliga fibersammansaettningar och foerfarande foer framstaellning daerav.
FI890648L (fi) Katalysatorer och dessa innehaollande epoxihartskomposition.
FI890980L (fi) Organiskt polymermaterial och jonbytesmembran framstaelld daerav.
FI893545A0 (fi) Maenskans protein c-mutanter och foerfarande foer deras framstaellning.
FI892177A0 (fi) Fibronektinbindande protein och dess framstaellning.
FI882761A0 (fi) Punktventilationsfoerfarande och punktventilationsanordning foer arbetspunkt.
FI884001A0 (fi) Siltrumma och foerfarande foer framstaellning daerav.
FI891560L (fi) Mottagare och en foer denna mottagare laemplig demoduleringskrets.
FI890869A7 (fi) Substituerade imidazolinoner och imidazolintioner.
FI891304A0 (fi) Kefalosprinderivat och deras framstaellningsfoerfarande.
FI881066A0 (fi) Foerfarande och anordning foer luftrening.
FI884002A0 (fi) Silplaot och foerfarande foer framstaellning daerav.
FI884767L (fi) Termoelektrisk kylare och automatisk spruta.
FI884257A0 (fi) Sugborr och sugborste.
FI880484A0 (fi) Loesflak och lastvaexlare.
FI884218A7 (fi) Foerfarande och anordning foer framstaellning spaonskivor.
FI884664L (fi) Pappersprodukt innehaollande latexpartiklar och foerfarande foer framstaellning daerav.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: HOECHST JAPAN LIMITED